T. Rowe Price Associates’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42K | Sell |
67,582
-21,988
| -25% | -$13.7K | ﹤0.01% | 3018 |
|
|
2025
Q1 | $52K | Sell |
89,570
-46,664
| -34% | -$27.1K | ﹤0.01% | 2921 |
|
|
2024
Q4 | $196K | Sell |
136,234
-2,892,201
| -96% | -$4.16M | ﹤0.01% | 2682 |
|
|
2024
Q3 | $5.85M | Sell |
3,028,435
-485,289
| -14% | -$937K | ﹤0.01% | 1251 |
|
|
2024
Q2 | $10.9M | Buy |
3,513,724
+167,202
| +5% | +$518K | ﹤0.01% | 1097 |
|
|
2024
Q1 | $17.5M | Sell |
3,346,522
-1,198,021
| -26% | -$6.27M | ﹤0.01% | 1006 |
|
|
2023
Q4 | $14.7M | Buy |
4,544,543
+69,377
| +2% | +$225K | ﹤0.01% | 1017 |
|
|
2023
Q3 | $11.4M | Buy |
4,475,166
+5,525
| +0.1% | +$14.1K | ﹤0.01% | 1050 |
|
|
2023
Q2 | $26.2M | Buy |
4,469,641
+82,858
| +2% | +$486K | ﹤0.01% | 860 |
|
|
2023
Q1 | $12.5M | Sell |
4,386,783
-85,419
| -2% | -$243K | ﹤0.01% | 1018 |
|
|
2022
Q4 | $8.99M | Buy |
4,472,202
+2,357,950
| +112% | +$4.74M | ﹤0.01% | 1070 |
|
|
2022
Q3 | $6.13M | Sell |
2,114,252
-1,252,528
| -37% | -$3.63M | ﹤0.01% | 1162 |
|
|
2022
Q2 | $19M | Buy |
3,366,780
+335,378
| +11% | +$1.89M | ﹤0.01% | 1180 |
|
|
2022
Q1 | $35.7M | Buy |
3,031,402
+37,899
| +1% | +$446K | ﹤0.01% | 1076 |
|
|
2021
Q4 | $55.6M | Buy |
2,993,503
+220,394
| +8% | +$4.09M | 0.01% | 962 |
|
|
2021
Q3 | $56M | Buy |
+2,773,109
| New | +$56M | 0.01% | 967 |
|